Moderna Therapeutics (Not covered): The new year begins with another huge deal!

News published on January Tuesday 14, 2014
Share on

Moderna Therapeutics announced an exclusive strategic agreement with Alexion to develop and commercialize pioneering messenger RNA therapeutics™ for the treatment of Rare diseases. Following the two deals already signed in 2013 with AstraZeneca and US army DARPA, Moderna is confirming the breakthrough potential of its mRNA Therpeutics platform.


Full report available to subscribers
Please contact marketing@bryangarnier.fr   

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities